Business FDA rejects wider use of J&J Xarelto for 3rd time Washington Examiner · February 14, 2014 5:46 pm
Business FDA reconsiders heart safety of common pain pills Matthew Perrone · February 10, 2014 9:36 pm
Business FDA clears first drug for blindness sleep disorder Washington Examiner · January 31, 2014 9:51 pm
Business Lilly 4Q profit falls 12 pct, hurt by patent loss Washington Examiner · January 30, 2014 12:45 pm
Business Stocks rise on Wall Street after 3 days of losses Steve Rothwell · January 28, 2014 10:31 pm
Healthcare FDA bureaucracy stifles access to life-saving drugs Erik Telford · January 23, 2014 5:00 am
Healthcare FDA panel again rejects wider use of J&J’s Xarelto Washington Examiner · January 16, 2014 9:38 pm
Op-Eds Grandstanding AGs sue to stop drugmaker’s work to insure patients take medicine properly Peter Pitts · January 14, 2014 5:00 am
Op-Eds FDA must decide if a biosimilar rose by any other name is still a rose Peter Pitts · December 9, 2013 5:00 am
